# SODium BICarbonate for Metabolic Acidosis in the ICU

> **NCT05697770** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Australian and New Zealand Intensive Care Research Centre** · enrollment: 500 (actual)

## Conditions studied

- Metabolic Acidosis
- Shock

## Interventions

- **DRUG:** Sodium bicarbonate
- **DRUG:** 5% Dextrose

## Key facts

- **NCT ID:** NCT05697770
- **Lead sponsor:** Australian and New Zealand Intensive Care Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-26
- **Primary completion:** 2026-01-08
- **Final completion:** 2026-07
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05697770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05697770, "SODium BICarbonate for Metabolic Acidosis in the ICU". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05697770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*